Flywell Kawonga
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Flywell Kawonga has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Dylo Pemba
1 shared publicationGerald Misinzo
1 shared publication- Glory Kaunda
Affiliation School of Global and Public Health, Kamuzu University of Health Sciences, Blantyre, Malawi
1 shared publication - Innocent Machillika
Affiliation School of Global and Public Health, Kamuzu University of Health Sciences, Blantyre, Malawi
1 shared publication - Isaac Thom Shawa
Kamuzu University of Health Sciences, Blantyre, Malawi
1 shared publication - Leonard E. G. Mboera
Affiliation SACIDS Foundation for One Health, Sokoine University of Agriculture, Morogoro, Tanzania
1 shared publication
Latest Publications
- Open Access
- 22 June 2026
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 6 (6) , e0006695
Burden and distribution of serologically detected HIV and syphilis infections among pregnant women attending antenatal care in peri-urban Blantyre, Malawi
Pregnant women are vulnerable to sexually transmitted infections (STIs), which can lead to adverse pregnancy outcomes. Evidence on STI prevalence and determinants among pregnant women in peri-urban Malawi remains limited. This study aimed to determine human immunodeficiency virus (HIV) and syphilis prevalence, identify associated factors and assess antenatal care (ANC) service quality among pregnant women in Blantyre peri-urban health facilities. A cross-sectional mixed-methods study was conducted at three peri-urban health centers (Zingwangwa, Ndirande, and Limbe). Quantitative data were retrospectively collected from facility records between January and June 2022 to determine STI diagnoses. Structured questionnaires assessed contributing factors and ANC service quality. Among 5,634 pregnant women tested for HIV, the prevalence of serologically detected HIV was 10.4% (95% confidence interval (CI): 9.7-11.3). Among 2,983 women tested for syphilis, the prevalence was 11.1% (95% CI: 10.0-12.3). The prevalence varied significantly by facility (p < 0.001), with the highest burden recorded at Limbe (HIV: 12.5%, 95% CI: 11.1-13.9; syphilis: 14.8%, 95% CI: 12.8-16.9), versus Ndirande (HIV: 10.5%, 95% CI: 9.1-12.1; syphilis: 8.4%, 95% CI: 6.7-10.3) and Zingwangwa (HIV: 7.5%, 95% CI: 6.2-8.9; syphilis: 8.9%, 95% CI: 7.0-11.0). Among women tested for both infections (n = 2,917), co-infection prevalence was 2.0% (95% CI: 1.6-2.6). Among 91 interviewed women (aged 14–43 years), unemployment (odds ratio (OR) 2.74, 95% CI: 1.07–7.03; p = 0.033) and lack of partner treatment (OR 2.83, 95% CI: 1.12–7.19; p = 0.025) were significantly associated with STI positivity. Although most participants were satisfied with ANC services, 64% reported that their partners were not treated, and no formal follow-up system existed, revealing gaps in partner management. The high HIV and syphilis prevalence highlights a pressing public health concern. Strengthening antenatal screening, improving partner management and implementing targeted interventions are essential to reduce HIV and syphilis burden among pregnant women in peri-urban Blantyre.
- 22 June 2026
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 6 (6) , e0006695
Open AccessBurden and distribution of serologically detected HIV and syphilis infections among pregnant women attending antenatal care in peri-urban Blantyre, Malawi
Pregnant women are vulnerable to sexually transmitted infections (STIs), which can lead to adverse pregnancy outcomes. Evidence on STI prevalence and determinants among pregnant women in peri-urban Malawi remains limited. This study aimed to determine human immunodeficiency virus (HIV) and syphilis prevalence, identify associated factors and assess antenatal care (ANC) service quality among pregnant women in Blantyre peri-urban health facilities. A cross-sectional mixed-methods study was conducted at three peri-urban health centers (Zingwangwa, Ndirande, and Limbe). Quantitative data were retrospectively collected from facility records between January and June 2022 to determine STI diagnoses. Structured questionnaires assessed contributing factors and ANC service quality. Among 5,634 pregnant women tested for HIV, the prevalence of serologically detected HIV was 10.4% (95% confidence interval (CI): 9.7-11.3). Among 2,983 women tested for syphilis, the prevalence was 11.1% (95% CI: 10.0-12.3). The prevalence varied significantly by facility (p < 0.001), with the highest burden recorded at Limbe (HIV: 12.5%, 95% CI: 11.1-13.9; syphilis: 14.8%, 95% CI: 12.8-16.9), versus Ndirande (HIV: 10.5%, 95% CI: 9.1-12.1; syphilis: 8.4%, 95% CI: 6.7-10.3) and Zingwangwa (HIV: 7.5%, 95% CI: 6.2-8.9; syphilis: 8.9%, 95% CI: 7.0-11.0). Among women tested for both infections (n = 2,917), co-infection prevalence was 2.0% (95% CI: 1.6-2.6). Among 91 interviewed women (aged 14–43 years), unemployment (odds ratio (OR) 2.74, 95% CI: 1.07–7.03; p = 0.033) and lack of partner treatment (OR 2.83, 95% CI: 1.12–7.19; p = 0.025) were significantly associated with STI positivity. Although most participants were satisfied with ANC services, 64% reported that their partners were not treated, and no formal follow-up system existed, revealing gaps in partner management. The high HIV and syphilis prevalence highlights a pressing public health concern. Strengthening antenatal screening, improving partner management and implementing targeted interventions are essential to reduce HIV and syphilis burden among pregnant women in peri-urban Blantyre.
- Open Access
- 17 May 2021
- Published by MDPI AG in Preprints.org
Seroprevalence and Clinical Presentation of Chikungunya Virus Infection among Febrile Outpatients Seeking Health Care in Mzuzu City, Malawi
Chikungunya is a mosquito-borne viral disease caused by Chikungunya virus (CHIKV. We conducted this study determine the seroprevalence and clinical presentation of Chikungunya infection among outpatients seeking healthcare in Mzuzu City, Malawi. Blood samples were collected from malaria negative and non-septic febrile outpatients with fevers ≥38 °C, for not more than 5 days. The enzyme- linked immunosorbent assay (ELISA) test was used to detect anti-CHIKV IgM antibodies and its results were used to determine seroprevalence of Chikungunya. A total of 119 serum samples were tested, of these, 73 (61.3%) tested positive for anti-CHIKV IgM antibodies by ELISA. Laboratory requisition forms were used to capture demographic information such as age, sex, clinical signs and symptoms presented by the enrolled patients. Age groups of 1-9, 10- 19, 20- 29, 30- 39, 40- 49, and ≥50 years had 17.8% (n= 13), 12.3 %,( n=9), 15.1%) (n=11), 19.2%; (n=14), 17.8% (n=13) and 17.8% (n=13) proportion of seroprevalence respectively. Most of the CHIKV infected individuals presented with fever (52.05%), joint pain (45.21%) and abdominal pain (42.67%). The presence of anti- CHIKV IgM antibodies suggest the presence of recent CHIKV infection and therefore accurate laboratory assays are highly recommended for CHIKV diagnosis and appropriate management of febrile patients.
- 17 May 2021
- Published by MDPI AG in Preprints.org
Open AccessSeroprevalence and Clinical Presentation of Chikungunya Virus Infection among Febrile Outpatients Seeking Health Care in Mzuzu City, Malawi
Chikungunya is a mosquito-borne viral disease caused by Chikungunya virus (CHIKV. We conducted this study determine the seroprevalence and clinical presentation of Chikungunya infection among outpatients seeking healthcare in Mzuzu City, Malawi. Blood samples were collected from malaria negative and non-septic febrile outpatients with fevers ≥38 °C, for not more than 5 days. The enzyme- linked immunosorbent assay (ELISA) test was used to detect anti-CHIKV IgM antibodies and its results were used to determine seroprevalence of Chikungunya. A total of 119 serum samples were tested, of these, 73 (61.3%) tested positive for anti-CHIKV IgM antibodies by ELISA. Laboratory requisition forms were used to capture demographic information such as age, sex, clinical signs and symptoms presented by the enrolled patients. Age groups of 1-9, 10- 19, 20- 29, 30- 39, 40- 49, and ≥50 years had 17.8% (n= 13), 12.3 %,( n=9), 15.1%) (n=11), 19.2%; (n=14), 17.8% (n=13) and 17.8% (n=13) proportion of seroprevalence respectively. Most of the CHIKV infected individuals presented with fever (52.05%), joint pain (45.21%) and abdominal pain (42.67%). The presence of anti- CHIKV IgM antibodies suggest the presence of recent CHIKV infection and therefore accurate laboratory assays are highly recommended for CHIKV diagnosis and appropriate management of febrile patients.